Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Treasury Shares: 2010-2024

Historic Treasury Shares for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $858,290.

  • Altimmune's Treasury Shares rose 44.85% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 44.85%. This contributed to the annual value of $858,290 for FY2024, which is 42.06% up from last year.
  • As of FY2024, Altimmune's Treasury Shares stood at $858,290, which was up 42.06% from $604,167 recorded in FY2023.
  • In the past 5 years, Altimmune's Treasury Shares ranged from a high of $858,290 in FY2024 and a low of $169,726 during FY2020.
  • For the 3-year period, Altimmune's Treasury Shares averaged around $625,647, with its median value being $604,167 (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first dropped by 27.98% in 2020, then soared by 78.71% in 2022.
  • Yearly analysis of 5 years shows Altimmune's Treasury Shares stood at $169,726 in 2020, then skyrocketed by 36.65% to $231,928 in 2021, then skyrocketed by 78.71% to $414,485 in 2022, then skyrocketed by 45.76% to $604,167 in 2023, then skyrocketed by 42.06% to $858,290 in 2024.